TTRX 10-Q: SEC filing
Turn Therapeutics Inc.
Filed with the SEC on · accession 0001213900-26-117186
TTRX filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. Turn Therapeutics Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing routine financial results, equity financings, and stock-based compensation activity. The stock moved +3.3% by the first close after the filing.
Summary of the filing
Turn Therapeutics Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing routine financial results, equity financings, and stock-based compensation activity. The filing includes details of Regulation D and Regulation A offerings, warrant activity, and related-party transactions.
Key details
How TTRX stock reacted
Close before
$9.48
Nov 6, 2026
First close after
+3.27%
$9.79
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for TTRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TTRX?
Click hereFrequently asked questions
What did TTRX file with the SEC on Nov 9, 2026?
TTRX filed a 10-Q (SEC filing). Turn Therapeutics Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing routine financial results, equity financings, and stock-based compensation activity. The filing includes details of Regulation D and Regulation A offerings, warrant activity, and related-party transactions.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did TTRX stock react to this filing?
TTRX closed at $9.48 before the filing and $9.79 on Nov 9, 2026 (+3.27%).
Other TTRX SEC filings
Get alerts when TTRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days